Eastman Chemical faced a 12% decline in revenue and significant drops in EBIT and net income in Q4 2025. Despite macroeconomic pressures, the company emphasized cost-saving initiatives and strategic progress on its methanolysis facility.

Eastman Chemical reported a decrease in sales revenue and EBIT in the third quarter of 2025, primarily due to lower sales volume/mix across all segments and reduced asset utilization. Despite these headwinds, the company delivered strong operating cash flow and made significant progress on inventory reduction, while maintaining stable prices in specialty businesses.

Eastman Chemical Company announced its second-quarter 2025 financial results, reporting sales revenue of $2,287 million and diluted EPS of $1.20. The company faced significant challenges including a tough macroeconomic backdrop, increased tariffs, and an unplanned outage in Chemical Intermediates, which impacted EBIT by approximately $20 million. Despite these headwinds, specialty businesses showed resilience, and the company continued to make progress with its circular platform.

Eastman Chemical delivered higher net income and EPS in Q1 2025, driven by margin expansion in key segments, even as total revenue declined slightly year-over-year.

Eastman Chemical Company reported a challenging fourth quarter due to lower demand in key markets, customer inventory destocking, and limited benefit from lower raw material costs. Despite these challenges, the company demonstrated commercial excellence in pricing and made progress on its circular platform.

Eastman Chemical Company reported a decrease in sales revenue and EBIT compared to the third quarter of 2019, but saw improved demand and adjusted earnings sequentially. The company is on track to generate greater than $1 billion of free cash flow for the fourth consecutive year.